TriangleNCT00392327 · OUTCOME
Tumor Response to Radiation Therapy for Patients With Supratentorial Primitive Neuroectodermal Tumor (SPNET)
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- percentage of patients
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- 12 weeks after treatment initiation
What was measured
Percentages of patients with responses after radiation therapy (induction therapy) are reported with 95% confidence intervals. Complete and partial responses were considered responses. SPNET is no longer recognized by WHO (World Health Organization) as a disease entity. Additional trial information can be found under PubMed® # 30332335.
Analysis population: 23 of 23 eligible Arm A SPNET patients were evaluated for response after induction, as were 18/19, 21/21, and 19/22 arm B, C, and D patients, respectively.
Groups in this outcome
Regimen A (SPNET Patients)
SPNET patients who received regimen A (no carboplatin / no isotretinoin)
Regimen B (SPNET Patients)
SPNET patients who received regimen B (carboplatin / no isotretinoin)
Regimen C (SPNET Patients)
SPNET patients who received regimen C (no carboplatin / isotretinoin)
Regimen D (SPNET Patients)
SPNET patients who received regimen D (carboplatin / isotretinoin)
| Group | Source count |
|---|---|
| Regimen A (SPNET Patients) | 23 |
| Regimen B (SPNET Patients) | 18 |
| Regimen C (SPNET Patients) | 21 |
| Regimen D (SPNET Patients) | 19 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Regimen A (SPNET Patients) | 69.9 | Not reported | 47.1 | 86.8 | Not reported |
| Regimen B (SPNET Patients) | 83.3 | Not reported | 58.6 | 96.4 | Not reported |
| Regimen C (SPNET Patients) | 66.7 | Not reported | 43.0 | 85.4 | Not reported |
| Regimen D (SPNET Patients) | 73.7 | Not reported | 48.8 | 90.9 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 47.1
- upper Limit
- 86.8
- value
- 69.9
- group Id
- OG001
- lower Limit
- 58.6
- upper Limit
- 96.4
- value
- 83.3
- group Id
- OG002
- lower Limit
- 43.0
- upper Limit
- 85.4
- value
- 66.7
- group Id
- OG003
- lower Limit
- 48.8
- upper Limit
- 90.9
- value
- 73.7
- denoms
- counts
- group Id
- OG000
- value
- 23
- group Id
- OG001
- value
- 18
- group Id
- OG002
- value
- 21
- group Id
- OG003
- value
- 19
- units
- Participants
- description
- Percentages of patients with responses after radiation therapy (induction therapy) are reported with 95% confidence intervals. Complete and partial responses were considered responses. SPNET is no longer recognized by WHO (World Health Organization) as a disease entity. Additional trial information can be found under PubMed® # 30332335.
- dispersion Type
- 95% Confidence Interval
- groups
- description
- SPNET patients who received regimen A (no carboplatin / no isotretinoin)
- id
- OG000
- title
- Regimen A (SPNET Patients)
- description
- SPNET patients who received regimen B (carboplatin / no isotretinoin)
- id
- OG001
- title
- Regimen B (SPNET Patients)
- description
- SPNET patients who received regimen C (no carboplatin / isotretinoin)
- id
- OG002
- title
- Regimen C (SPNET Patients)
- description
- SPNET patients who received regimen D (carboplatin / isotretinoin)
- id
- OG003
- title
- Regimen D (SPNET Patients)
- param Type
- NUMBER
- population Description
- 23 of 23 eligible Arm A SPNET patients were evaluated for response after induction, as were 18/19, 21/21, and 19/22 arm B, C, and D patients, respectively.
- reporting Status
- POSTED
- time Frame
- 12 weeks after treatment initiation
- title
- Tumor Response to Radiation Therapy for Patients With Supratentorial Primitive Neuroectodermal Tumor (SPNET)
- type
- SECONDARY
- unit Of Measure
- percentage of patients
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice